<DOC>
	<DOCNO>NCT00224679</DOCNO>
	<brief_summary>Experimental epidemiologic study suggest aspirin intake reduces risk colorectal cancer . In APACC study randomly assign 291 patient daily Aspirin Placebo 4 year . However , available data sufficient serve basis firm recommendation</brief_summary>
	<brief_title>APACC Study : Prospective Study Aspirin Efficacy Reducing Colorectal Adenoma Recurrence</brief_title>
	<detailed_description>The APACC Study prospect , randomize , double-blind , placebo-controlled multicentre clinical trial design test efficacy regular low-dose aspirin administration reduce recurrence rate colorectal adenomatous polyp . The study involve 49 gastroenterology center various part France . Patients eligible either least 3 adenomas irrespective size , least one measure 6mm diameter histologically confirm colorectal adenomatous polyp local pathologist , 2 independent pathologist , underwent complete colonoscopy polypectomy confirm free polyp , age 18 75 year recruitment , able conform protocol study period . During 4-week run-in period enrolment , subject take 300 mg aspirin per day test tolerance compliance treatment . They randomize either follow three group : placebo , aspirin acetylsalicylate lysine 160 mg/day aspirin acetylsalicylate lysine 300 mg/day . Information compliance , tolerance treatment concomitant disease obtain regular clinical visit every 4 month . Informations factor smock habit , previous medical history record enrollment . The primary outcome define proportion subject least one new adenoma detect , adenomatous polyp burden calculate sum diameter adenomas follow-up colonoscopy 1 4 year enrollment .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Patients age 18 75 year At least 3 adenomas irrespective size least one measure 6mm All subject clean colon study entry No personal history colon cancer , inflammatory bowel disease , familial adenomatous polyposis , regular use aspirin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Colon cancer</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Adenomas</keyword>
	<keyword>Prevention</keyword>
</DOC>